Literature DB >> 11751452

Human cytochrome P-450 (CYP) genes: a web page for the nomenclature of alleles.

M Ingelman-Sundberg, M Oscarson, A K Daly, S Garte, D W Nebert.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11751452

Source DB:  PubMed          Journal:  Cancer Epidemiol Biomarkers Prev        ISSN： 1055-9965            Impact factor:   4.254


× No keyword cloud information.
  15 in total

1.  Biomarkers for antiepileptic drug response.

Authors:  Tracy A Glauser
Journal:  Biomark Med       Date:  2011-10       Impact factor: 2.851

Review 2.  Role of cytochrome P450 activity in the fate of anticancer agents and in drug resistance: focus on tamoxifen, paclitaxel and imatinib metabolism.

Authors:  Bertrand Rochat
Journal:  Clin Pharmacokinet       Date:  2005       Impact factor: 6.447

3.  Identification of CYP2C19*4B: pharmacogenetic implications for drug metabolism including clopidogrel responsiveness.

Authors:  S A Scott; S Martis; I Peter; Y Kasai; R Kornreich; R J Desnick
Journal:  Pharmacogenomics J       Date:  2011-03-01       Impact factor: 3.550

4.  Genetic polymorphisms in the cytochromes P-450 (1A1, 2E1), microsomal epoxide hydrolase and glutathione S-transferase M1, T1, and P1 genes, and their relationship with chronic bronchitis and relapsing pneumonia in children.

Authors:  G F Korytina; D G Yanbaeva; L I Babenkova; E I Etkina; T V Victorova
Journal:  J Mol Med (Berl)       Date:  2005-06-01       Impact factor: 4.599

5.  ["Genes for mitochondria" in arterial hypertension and left ventricular hypertrophy].

Authors:  S V Buĭkin; M V Golubenko; V P Puzyrev
Journal:  Mol Biol (Mosk)       Date:  2010 Jan-Feb

6.  Possible risk modification by CYP1A1, GSTM1 and GSTT1 gene polymorphisms in lung cancer susceptibility in a South Indian population.

Authors:  Leelakumari Sreeja; Vani Syamala; Sreedharan Hariharan; Jayaprakash Madhavan; Sivanandan Choondal Devan; Ravindran Ankathil
Journal:  J Hum Genet       Date:  2005-10-14       Impact factor: 3.172

7.  Relationship among metabolizing genes, smoking and alcohol used as modifier factors on prostate cancer risk: exploring some gene-gene and gene-environment interactions.

Authors:  Dante D Cáceres; Jeannette Iturrieta; Cristian Acevedo; Christian Huidobro; Nelson Varela; Luis Quiñones
Journal:  Eur J Epidemiol       Date:  2005       Impact factor: 8.082

Review 8.  PharmVar GeneFocus: CYP2D6.

Authors:  Charity Nofziger; Amy J Turner; Katrin Sangkuhl; Michelle Whirl-Carrillo; José A G Agúndez; John L Black; Henry M Dunnenberger; Gualberto Ruano; Martin A Kennedy; Michael S Phillips; Houda Hachad; Teri E Klein; Andrea Gaedigk
Journal:  Clin Pharmacol Ther       Date:  2019-12-09       Impact factor: 6.875

Review 9.  Human drug metabolising cytochrome P450 enzymes: properties and polymorphisms.

Authors:  Magnus Ingelman-Sundberg
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2003-10-22       Impact factor: 3.000

10.  Meta-analysis and pooled analysis of GSTM1 and CYP1A1 polymorphisms and oral and pharyngeal cancers: a HuGE-GSEC review.

Authors:  Leonor Varela-Lema; Emanuela Taioli; Alberto Ruano-Ravina; Juan M Barros-Dios; Devasena Anantharaman; Simone Benhamou; Stefania Boccia; Rajani A Bhisey; Gabriella Cadoni; Ettore Capoluongo; Chien-Jen Chen; William Foulkes; Eny Maria Goloni-Bertollo; Ana Hatagima; Richard B Hayes; Takahiko Katoh; Sergio Koifman; Phillip Lazarus; Johannes J Manni; Manoj Mahimkar; Shunji Morita; Jong Park; Kwang-Kyun Park; Erika Cristina Pavarino Bertelli; Enilze Maria de Souza Fonseca Ribeiro; Bidyut Roy; Margaret R Spitz; Richard C Strange; Qingyi Wei; Camille C Ragin
Journal:  Genet Med       Date:  2008-06       Impact factor: 8.822
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.